<VariationArchive RecordType="classified" VariationID="5777" VariationName="NM_003919.2(SGCE):c.464_662del" VariationType="Deletion" Accession="VCV000005777" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-09-03" DateCreated="2017-12-26" MostRecentSubmission="2017-12-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="20816" VariationID="5777">
      <GeneList>
        <Gene Symbol="CASD1" FullName="CAS1 domain containing 1" GeneID="64921" HGNC_ID="HGNC:16014" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="94509809" stop="94634172" display_start="94509809" display_stop="94634172" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="94139169" stop="94186330" display_start="94139169" display_stop="94186330" Strand="+" />
          </Location>
          <OMIM>611686</OMIM>
        </Gene>
        <Gene Symbol="SGCE" FullName="sarcoglycan epsilon" GeneID="8910" HGNC_ID="HGNC:10808" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="94584980" stop="94656133" display_start="94584980" display_stop="94656133" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="94214535" stop="94285520" display_start="94214535" display_stop="94285520" Strand="-" />
          </Location>
          <OMIM>604149</OMIM>
          <Haploinsufficiency last_evaluated="2021-11-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SGCE">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-11-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SGCE">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003919.2(SGCE):c.464_662del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="94604254" stop="94619273" display_start="94604254" display_stop="94619273" Strand="-" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="94233566" stop="94248585" display_start="94233566" display_stop="94248585" variantLength="15020" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008893.1" sequenceAccession="NG_008893" sequenceVersion="1" change="g.41937_56956del">
            <Expression>NG_008893.1:g.41937_56956del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.94233566_94248585del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.94233566_94248585del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="604149.0010" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">15,020-nt genomic deletion beginning in intron 4 and ending in intron 5 of gene SGCE, resulting in the loss of exon 5 from the cDNA product.</Comment>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 16240355 to determine the location of this allele on the current reference sequence.</Comment>
      <Comment DataSource="NCBI curation" Type="LocationOnGenomeAndProductNotAligned">Genomic deletion beginning in intron 4 and ending in intron 5 of gene SGCE results in the loss of exon 5 from the cDNA product.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003919.2(SGCE):c.464_662del AND Myoclonic dystonia 11" Accession="RCV000006133" Version="5">
        <ClassifiedConditionList TraitSetID="1614">
          <ClassifiedCondition DB="MedGen" ID="C1834570">Myoclonic dystonia 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2005-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-12-26" MostRecentSubmission="2017-12-26">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16240355</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1614" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3138" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dystonia, alcohol responsive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary essential myoclonus</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYT-SGCE</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myoclonus-Dystonia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Myoclonic dystonia 11</ElementValue>
                <XRef ID="MONDO:0008044" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia 11</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myoclonic dystonia</ElementValue>
                <XRef ID="Dystonia+11/2408" DB="Genetic Alliance" />
                <XRef ID="439732004" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DYT11</ElementValue>
                <XRef Type="MIM" ID="159900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">SGCE myoclonus-dystonia (SGCE-M-D) is a movement disorder characterized by a combination of rapid, brief muscle contractions (myoclonus) and/or sustained twisting and repetitive movements that result in abnormal postures (dystonia). The myoclonic jerks typical of SGCE-M-D most often affect the neck, trunk, and upper limbs with less common involvement of the legs. Approximately 50% of affected individuals have additional focal or segmental dystonia, presenting as cervical dystonia and/or writer's cramp. Non-motor features may include alcohol abuse, obsessive-compulsive disorder (OCD), and anxiety disorders. Symptom onset is usually in the first decade of life and almost always by age 20 years, but ranges from age six months to 80 years. Most affected adults report a dramatic reduction in myoclonus in response to alcohol ingestion. SGCE-M-D is compatible with an active life of normal span.</Attribute>
                <XRef ID="NBK1414" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301587</ID>
                <ID Source="BookShelf">NBK1414</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <XRef ID="36899" DB="Orphanet" />
              <XRef ID="C1834570" DB="MedGen" />
              <XRef ID="MONDO:0008044" DB="MONDO" />
              <XRef Type="MIM" ID="159900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26315" SubmissionDate="2017-12-22" DateLastUpdated="2017-12-26" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604149.0010_DYSTONIA 11, MYOCLONIC" title="SGCE, 15,020-BP DEL, EX5DEL_DYSTONIA 11, MYOCLONIC" />
        <ClinVarAccession Accession="SCV000026315" DateUpdated="2017-12-26" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 5 affected members of a German pedigree with myoclonus-dystonia syndrome (DYT11; 159900), Asmus et al. (2005) identified a heterozygous 15,020-bp deletion in the SGCE gene, resulting in the deletion of exon 5 and termination before the transmembrane domain. The deletion was paternally inherited in all cases. Asmus et al. (2005) suggested nonhomologous end joining as the molecular mechanism for the deletion.</Attribute>
              <Citation>
                <ID Source="PubMed">16240355</ID>
              </Citation>
              <XRef DB="OMIM" ID="159900" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SGCE" />
          </GeneList>
          <Name>SGCE, 15,020-BP DEL, EX5DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">15,020-BP DEL, EX5DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604149.0010" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DYSTONIA 11, MYOCLONIC</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="26315" TraitType="Disease" MappingType="Name" MappingValue="DYSTONIA 11, MYOCLONIC" MappingRef="Preferred">
        <MedGen CUI="C1834570" Name="Myoclonic dystonia 11" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

